1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 7:Results of treatment on mass effect
Optic nerve compression Baseline At Discharge 12-Month or Latest Follow-up No. of patients 14 Improved/resolved 2 6 Unchanged 11 7 Worsened 1 1 Additional patients 1 0* *1 no follow up to date Occulo-motor deficits Baseline At Discharge 12-Month or Latest Follow-up No. of patients 16 Improved/resolved 6 14 Unchanged 8 1 Worsened 1 1 1 = died prior discharge Hemiparesis or hemiplegia Baseline At Discharge 12-Month or Latest Follow-up No. of patients 8 Improved/resolved 1 5 Unchanged 5 1 Worsened 0 0 2* = died Headache (all), n = 57 at baseline Baseline At Discharge 12-Month or Latest Follow-up Mild/moderate No. of patients 48 Improved/resolved 43 42 Unchanged 2 1 Worsened 0 2 3 = died At Discharge 12-Month or Latest Follow-up Severe No. of patients 9 Improved/resolved 8 8 Unchanged 1 0 Worsened 0 0 1 = lost to follow up